Molar Concentrations of Fibrinolytic Components, Especially Free Fibrinolysin, in Vivo

Summary

The levels of fibrinogen and of Profibrinolysin (plasminogen) in urokinase-treated plasma as a function of time of incubation were measured. The Profibrinolysin concentration was estimated through its complete conversion to fibrinolysin and the inhibition of the enzyme by crystalline soybean trypsin inhibitor. The dissociation constant of the FL-STX complex was determined to be 7 × 10^–9 M. The average concentration of Profibrinolysin in normal human citrated plasma was found to be 8 × 10^–7 M. From the decrease of fibrinogen with time in the urokinase-treated plasma, the free fibrinolysin was calculated. Free fibrinolysin in normal human blood in vivo was estimated from the half-life of fibrinogen and other data obtained in this study to be present at a concentration of 1.7 × 10^–10 M. The plasmakinase activity in vivo, expressed as urokinase molarity, is also about 2 × 10^–10 M.

• References

• 1 Astrup T. In: Page I. H. (ed.) Connective Tissue. Thrombosis and Atherosclerosis Academic Press; New York: 1959: 224
• 2 Barlow G. H, Summaria L, Robbins K. C. Molecular weight studies on human Profibrinolysin and fibrinolysin at the microgram level. Journal of Biological Chemistry 1969; 244: 1138
• 3 Berg W, Korsan-Bengtsen K, Ygge J. Plasminogen assay by means of the lysis time method. Thrombosis et Diathesis Haemorrhagica 1965; 14: 127
• 4 Blombäck B, Carlson L. A, Franzen S, Zetterquist E. Turnover of I¹³¹-labelled fibrinogen in man. Acta medica Scandinavica 1966; 179: 557
• 5 Bray H. G, White K. Kinetics and Thermodynamics in Biochemistry. Academic Press; New York: 1957: 221
• 6 Collen L, Tytgat G, Claeys H, Wallen P. Metabolism of plasminogen in healthy subjects: effects of tranexamic acid. Journal of Clinical Investigation 1972; 51: 1310
• 7 Copley A. L. In: Copley A. L, Stainsby G. (eds.) Flow Properties of Blood. Pergamon Press; Oxford and New York: 1960
• 8 Dixon M, Webb E. C. Enzymes. Academic Press; New York: 1958: 486
• 9 Green N. M, Work E. Pancreatic trypsin inhibitor. Reaction with trypsin. Biochemical Journal 54 1953; 347
• 10 Harker L. A, Slichter S. J. Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thrombosis et Diathesis Haemorrhagica 1974; 31: 188
• 11 Harry J. B, Steiner R. F. A soybean proteinase inhibitor; thermodynamic and kinetic parameters of association with enzymes. European Journal of Biochemistry 1970; 16: 174
• 12 Hart H. C. The biological half-life of I¹³¹-fibrinogen. Thrombosis et Diathesis Haemorrhagica Suppl. 1965; 17: 121
• 13 Hart H. C, Meuwissen O. J.Th. La demi-vie biologique du fibrinogène, marqué a l’aide d’iode radioactif (I¹³¹) dans les cas d’hypercholesterolemie et d’affections vasculaires artérielles. Coagulation 1968; 1: 43
• 14 Koide T, Ikenaka T. Studies on soybean trypsin inhibitors. I. Fragmentation of soybean trypsin inhibitor (Kunitz) by limited proteolysis and by chemical cleavage. European Journal of Biochemistry 1973; 32: 401
• 15 Lesuk A. L, Terminiello L, Traver J. H. Crystalline urokinase; some properties. Science 1964; 147: 880
• 16 Martin Ch. J. Inhibition of trypsin, chymotrypsin and plasmin by an inhibitor isolated from sheep serum. Journal of Biological Chemistry 1962; 237: 2099
• 17 Maxwell R. E, Nickel V. S, Lewandowski V. Preparations of plasminogen deficient fibrinogen and thrombin. Biochemical and Biophysical Research Communications 50 7 1962;
• 18 Nanninga L. B. Fibrinogen preparation, photoelectric determination and viscosity, formol titration before and after clotting. Archives néerlandaises de physiologie de l’homme et des animaux 1946; 28: 1
• 19 Nanninga L. B. Rapid determination of Profibrinolysin (plasminogen) in plasma. Thrombosis et Diathesis Haemorrhagica 1967; 17: 8
• 20 Nanninga L. B, Guest M. M. Rapid determination of antifibrinolysin (antiplasmin) in plasma. Thrombosis et Diathesis Haemorrhagica 1966; 15: 273
• 21 Nanninga L. B, Guest M. M. Activity-pH relationship and Michaelis constants during activation of Profibrinolysin and during fibrinogenolysis. Thrombosis et Diathesis Haemorrhagica 1968; 19: 492
• 22 Nanninga L. B, Guest M. M. Fibrinolytic activation of plasma by means of urokinase in vitro and in vivo. Thrombosis et Diathesis Haemorrhagica 1970; 24: 33
• 23 Nanninga L. B, Guest M. M. Antiactivator (antikinase) activity of human plasma and its blocking by parachloromercuribenzoate and salicylate. Thrombosis et Diathesis Haemorrhagica 1971; 26: 541
• 24 Nolf P. Les modifications de la coagulation du sang chez le chien après extirpation du foie. Archives internationales de physiologie 1905; 3: 1
• 25 Steiner R. F. Reversible association processes of globular proteins. VI. The combination of trypsin with soybean inhibitor.. Archives of Biochemistry and Biophysics 1954; 49: 71
• 26 Summaria L, Hsieh B, Groskopf W. R, Robbins K. C, Barlow G. H. The isolation and characterization of the S-carboxymethyl (light) chain derivative of human plasmin. Journal of Biological Chemistry 1967; 242: 5046
• 27 Tytgat D, Collen D, de Vreker R. A. La diathèse hémorragique en cas de cirrhose du foie. Coagulation 1968; 1: 43